相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment of Glioblastoma Multiforme with Radiotherapy and Concomitant and Adjuvant Temozolomide: Translation of Randomised Controlled Trial Evidence into Routine Clinical Practice
C. Herbert et al.
CLINICAL ONCOLOGY (2011)
Advances in MRI Assessment of Gliomas and Response to Anti-VEGF Therapy
Whitney B. Pope et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab
Michael Prados et al.
NEURO-ONCOLOGY (2011)
Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab
Benjamin M. Ellingson et al.
NEURO-ONCOLOGY (2011)
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
Martha Nowosielski et al.
NEURORADIOLOGY (2011)
Pseudoprogression Following Chemoradiotherapy for Glioblastoma Multiforme
Paul Sanghera et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2010)
Should biomarkers be used to design personalized medicine for the treatment of glioblastoma?
Michael Weller et al.
FUTURE ONCOLOGY (2010)
Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
Patrick Y. Wen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Quantitative MR in Multi-center Clinical Trials
Edward Ashton
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Validation of Functional Diffusion Maps (fDMs) as a Biomarker for Human Glioma Cellularity
Benjamin M. Ellingson et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker
Rajan Jain et al.
JOURNAL OF NEURO-ONCOLOGY (2010)
Standardization of Relative Cerebral Blood Volume (rCBV) Image Maps for Ease of Both Inter- and Intrapatient Comparisons
Devyani Bedekar et al.
MAGNETIC RESONANCE IN MEDICINE (2010)
A Vascular Normalization Index as Potential Mechanistic Biomarker to Predict Survival after a Single Dose of Cediranib in Recurrent Glioblastoma Patients
A. Gregory Sorensen et al.
CANCER RESEARCH (2009)
Pseudoprogression and pseudoresponse in the treatment of gliomas
Dieta Brandsma et al.
CURRENT OPINION IN NEUROLOGY (2009)
Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Henry S. Friedman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
Whitney B. Pope et al.
RADIOLOGY (2009)
Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
Kathleen R. Lamborn et al.
NEURO-ONCOLOGY (2008)
Bevacizumab for recurrent malignant gliomas - Efficacy, toxicity, and patterns of recurrence
A. D. Norden et al.
NEUROLOGY (2008)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma
Marc C. Chamberlain et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Diffusion imaging: Insight to cell status and cytoarchitecture
Thomas L. Chenevert et al.
NEUROIMAGING CLINICS OF NORTH AMERICA (2006)
Potential of diffusion imaging in brain tumors: A review
M. K. Bode et al.
ACTA RADIOLOGICA (2006)
分享论文
